Clinical Microbiomics

Hørsholm, Denmark Founded: 2016 • Age: 10 yrs
Meta-genomics platforms and services for microbiome studies are provided.

About Clinical Microbiomics

Clinical Microbiomics is a Healthcare company based in Hørsholm (Denmark) founded in 2016. Meta-genomics platforms and services for microbiome studies are provided. Clinical Microbiomics has raised $9.71 million across 4 funding rounds from investors including European Union and Seventure Partners. The company has 35 employees. Clinical Microbiomics has completed 2 acquisitions, including DNASense and MS-Omics. Clinical Microbiomics offers products and services including Metagenomics, Metabolomics, Human Microbiome Profiling, and Multi-omics Data Integration. Its focus areas include Life Sciences, Genomics, Genomics Research and Metagenomics. Its legal entity is Clinical-Microbiomics A/S.

Company details

Clinical Microbiomics was founded in 2016 in Horsholm, Denmark, as a provider in the microbiome sector. A range of services is offered, including kits supply, sample storage, metagenomics, transcriptomics, specialized characterization through real-time qPCR and strain typing, bioinformatics, and statistical analysis. Customized sequencing solutions are developed according to specific project requirements.

  • Headquarters Hørsholm, Denmark
  • Employees 35
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website clinical-microbiomics.com
  • Social LinkedIn X
  • Legal Name Clinical-Microbiomics A/S
Key Metrics
  • Net Profit
    -$978.52 K (USD)
    -301
    as on Dec 31, 2022
  • EBITDA
    -$1.02 M (USD)
    -183
    as on Dec 31, 2022
  • Total Equity Funding
    $9.71M (USD)

    in 4 rounds

  • Latest Funding Round
    $9.71M (USD), Series A

    Oct 2022

  • Investors
  • Employee Count
    35
  • Investments & Acquisitions
    DNASense

    & 1 more

Products & Services of Clinical Microbiomics

Clinical Microbiomics offers a comprehensive portfolio of products and services, including Metagenomics, Metabolomics, Human Microbiome Profiling, and Multi-omics Data Integration.

Metagenomics
Genomic Analysis

Service for profiling microbial communities in samples using sequencing techniques.

Metabolomics
Metabolic Analysis

Analysis of microbial metabolic fingerprints for health and disease research.

Human Microbiome Profiling
Data Analysis

Tool for assessing microbiome abundances and functional aspects in human studies.

Multi-omics Data Integration
Integrated Analytics

Combines genomics and metabolomics data for comprehensive biological insights.

Funding Insights of Clinical Microbiomics

Clinical Microbiomics has successfully raised a total of $9.71M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $9.71 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $9.71M
  • Total Rounds 4
  • Last Round Series A — $9.71M
  • First Round $345,722

    (Sep 2018)

  • Investors Count 2

All 4 funding rounds of Clinical Microbiomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2022$9.71MSeries A–Seventure Partners
–
Jan 2021$364,873Grant––
Sep 2020$354,732Grant––
Sep 2018$345,722Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Clinical Microbiomics

Clinical Microbiomics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Seventure Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
seventure.frParis, France
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Clinical Microbiomics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Clinical Microbiomics

Clinical Microbiomics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include DNASense and MS-Omics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Genetic engineering services including sequencing and metagenomics are provided.
dnasense.comAalborg, Denmark2014Mar 2024••••
Metabolomics and data analysis platform is provided by MS-Omics.
msomics.comVedbaek, Denmark2014Oct 2022••••
Premium access

Complete acquisition details for Clinical Microbiomics

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Clinical Microbiomics

5 dated milestones of Clinical Microbiomics across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Clinical Microbiomics is founded.
  2. Funding First funding round of $346K.
  3. Funding Latest funding round, Series A, of $9.7M.
  4. Acquisition Acquires MS-Omics.
  5. Acquisition Acquires DNASense.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Clinical Microbiomics

Premium access

Complete news archive for Clinical Microbiomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Clinical Microbiomics

Clinical Microbiomics was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Clinical Microbiomics is headquartered in Hørsholm, Denmark.

Clinical Microbiomics is a funded company, having raised a total of $9.71M across 4 funding rounds to date. The company's 1st funding round was a Grant of $345.72K, raised on Sep 2018.

Clinical Microbiomics has 35 employees.

Clinical Microbiomics was founded in 2016 in Horsholm, Denmark, as a provider in the microbiome sector. A range of services is offered, including kits supply, sample storage, metagenomics, transcriptomics, specialized characterization through real-time qPCR and strain typing, bioinformatics, and statistical analysis. Customized sequencing solutions are developed according to specific project requirements.

Clinical Microbiomics offers Metagenomics, Metabolomics, Human Microbiome Profiling, and Multi-omics Data Integration.

Clinical Microbiomics has made 2 acquisitions, including DNASense, and MS-Omics.

Clinical Microbiomics has 2 investors. Key investors include European Union, and Seventure Partners.

Clinical Microbiomics operates through Clinical-Microbiomics A/S.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available